Chemed Corp stock (US1638321034): Presentation at RBC Healthcare Conference

Chemed Corp (NYSE:CHE) announced on May 13, 2026, it will present at the 2026 RBC Global Healthcare Conference, signaling engagement with investors amid shares trading at $420.89 with a 0.3% gain.

Chemed Corp, trading as CHE on the NYSE, disclosed on May 13, 2026, that it will deliver a presentation at the 2026 RBC Capital Markets Global Healthcare Conference, according to a GlobeNewswire release as of 05/13/2026. The event provides a platform for management to discuss strategy and outlook. Shares closed at $420.89, up 0.3% and recognized as a dividend contender with over 10 years of increases, per MarketBeat as of 05/14/2026.

As of: 14.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Chemed Corporation
• Sector/industry: Healthcare services
• Headquarters/country: United States
• Core markets: US hospice and plumbing services
• Key revenue drivers: VITAS Healthcare, Roto-Rooter
• Home exchange/listing venue: NYSE (CHE)
• Trading currency: USD

Chemed Corp: core business model

Chemed Corp operates through two main segments: VITAS Healthcare, providing hospice and palliative care, and Roto-Rooter, a leading plumbing and drain cleaning service. The company generates revenue primarily from healthcare services in the US, with VITAS serving patients facing life-limiting illnesses. This dual-model structure diversifies exposure across healthcare and essential home services, appealing to US investors seeking stability in defensive sectors.

Headquartered in Cincinnati, Ohio, Chemed focuses on high-quality service delivery. VITAS operates in 14 states, emphasizing end-of-life care, while Roto-Rooter provides nationwide emergency plumbing. This setup supports consistent cash flows, relevant for US portfolios amid economic cycles.

Main revenue and product drivers for Chemed Corp

VITAS Healthcare drives the majority of revenue, contributing over 70% in recent periods through hospice admissions and daily patient care fees reimbursed by Medicare and private insurers. Roto-Rooter adds steady income from service calls and maintenance contracts. Combined, these segments delivered reliable performance, with shares recognized for dividend growth over a decade.

Key drivers include aging US demographics boosting hospice demand and recurring plumbing needs in residential markets. Chemed's focus on operational efficiency supports margins, making it a notable player for US investors tracking healthcare services.

Industry trends and competitive position

The US hospice sector grows with an aging population, projected to expand as baby boomers retire. Chemed's VITAS competes with larger providers but maintains a strong regional footprint. In plumbing, Roto-Rooter holds a premium brand position against fragmented local competitors.

Trends like value-based care and home services digitization favor Chemed's model. Its listing on NYSE provides liquidity for US retail investors.

Why Chemed Corp matters for US investors

Chemed offers exposure to defensive US healthcare and consumer services, with VITAS tied to Medicare trends and Roto-Rooter to housing stability. NYSE listing ensures accessibility, while dividend history attracts income-focused portfolios. The RBC conference presentation underscores visibility amid healthcare sector interest.

Conclusion

Chemed Corp's announcement of its RBC Healthcare Conference presentation highlights ongoing investor engagement, complementing its position as a dividend contender. With shares stable near $420 and dual-segment resilience, the company remains relevant for US investors in healthcare services. Market dynamics and sector trends will shape near-term developments.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.